Search Results 191-200 of 1749 for ���������������������katalk:po03���������������������,������������������,������������������,������������������

  1. Phase 3 Program to Evaluate MK-7240 for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices. Medical records research — uses historical ...

  2. An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors - Mayo Clinic

    The following tumor types are included in this study: Non-Small Cell Lung Cancer (NSCLC), gastric cancer, hepatocellular carcinoma, renal cell carcinoma, ...

  3. https://www.mayoclinic.org/spanish_patient_consumer_recipe.xml

  4. Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer - Mayo Clinic

    About this study. In pancreatic cancer, targeting the tumor microenvironment has become a promising therapeutic strategy. Focal adhesion kinase (FAK) ...

  5. https://www.mayoclinic.org/arabic_organization_concepts.xml

  6. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of IV administration of VX15/2503 in combination with a fixed dose of avelumab in patients ...

  7. A Dose Titration Study to Assess the Effects of SAR407899 in Patients With Microvascular Angina and/or Persistent Stable Angina Despite Angiographically Successful Elective PCI - Mayo Clinic

    - To assess SAR407899 plasma concentrations in microvascular angina patients and/or persistent stable angina despite angiographically successful elective PCI.

  9. A Study to Assess the Effectiveness and Safety of PT009 Compared to PT005 for the Prevention of Moderate to Severe Episodes of Worsening COPD - Mayo Clinic

    The purpose of this study is to assess the safety and effectiveness of PT009 compared with PT005 for the prevention of moderate to very severe episodes of ...

  10. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...